Internal Medicine · Shreveport, LA
NPI
1003810904
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1455 E Bert Kouns Loop
Shreveport, LA, 71105
Phone (318) 798-4488
Groups this clinician bills Medicare through
Medicare paid, 2024
$362K
26,232 services
Medicare patients, 2024
547
Average age 76
Drug cost, 2024
$1.5M
14,950 prescriptions
Company payments, 2025
$1,802
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul A Rushing was code 36415 (venipuncture blood collection), 1,021 times for 430 patients. In total Paul A Rushing billed 26,232 services in 121 codes, and Medicare paid $362K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 1,021 | 430 | $8.66 | $8,844 |
| 80053 Clinical Chemistry | Office | 953 | 433 | $10.33 | $9,844 |
| 80061 Clinical Chemistry | Office | 864 | 413 | $13.03 | $11K |
| 99214 Office E&M - Established | Office | 863 | 412 | $79.17 | $68K |
| 85025 Blood Count | Office | 763 | 421 | $7.59 | $5,793 |
| 83036 Blood Count | Office | 405 | 191 | $9.52 | $3,855 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 341 | 341 | $121.23 | $41K |
| 81001 Clinical Chemistry | Office | 332 | 263 | $3.09 | $1,024 |
| 84443 Clinical Chemistry | Office | 272 | 218 | $16.46 | $4,477 |
| G0008 Administration of influenza virus vaccine | Office | 216 | 213 | $30.16 | $6,515 |
| 90662 Vaccine Product | Office | 213 | 210 | $81.40 | $17K |
| 96372 Injection Administration | Office | 103 | 47 | $9.43 | $971 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 85 | 17 | $0.08 | $6.76 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | Office | 69 | 69 | $18.80 | $1,297 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 69 | 55 | $152.66 | $11K |
By year: 2022 $253K for 23,221 services; 2023 $343K for 25,942 services; 2024 $362K for 26,232 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,021 | 430 | $8.66 | $8,844 |
| 80053 Clinical Chemistry | 953 | 433 | $10.33 | $9,844 |
| 80061 Clinical Chemistry | 864 | 413 | $13.03 | $11K |
| 85025 Blood Count | 763 | 421 | $7.59 | $5,793 |
| 83036 Blood Count | 405 | 191 | $9.52 | $3,855 |
| 81001 Clinical Chemistry | 332 | 263 | $3.09 | $1,024 |
| 84443 Clinical Chemistry | 272 | 218 | $16.46 | $4,477 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 69 | 69 | $18.80 | $1,297 |
| 84153 Clinical Chemistry | 52 | 48 | $18.02 | $937 |
| 85652 Clinical Chemistry | 35 | 32 | $2.65 | $92.75 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul A Rushing prescribed most often to Medicare patients was Atorvastatin Calcium, with 908 prescriptions and refills. In total Paul A Rushing wrote 14,950 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 908 | 2,502 | 233 | $8,379 |
| Amlodipine Besylate Generic | 567 | 1,524 | 144 | $2,926 |
| Levothyroxine Sodium Generic | 530 | 1,380 | 130 | $4,433 |
| Pantoprazole Sodium Generic | 485 | 1,227 | 130 | $6,023 |
| Losartan Potassium Generic | 411 | 1,080 | 108 | $4,198 |
| Gabapentin Generic | 341 | 665 | 85 | $5,411 |
| Metoprolol Succinate Generic | 326 | 897 | 89 | $4,227 |
| Lisinopril Generic | 310 | 837 | 79 | $2,013 |
| Furosemide Generic | 300 | 722 | 94 | $1,027 |
| Meloxicam Generic | 283 | 590 | 77 | $1,596 |
| Rosuvastatin Calcium Generic | 261 | 641 | 75 | $5,828 |
| Sertraline Hcl Generic | 235 | 569 | 60 | $1,392 |
| Simvastatin Generic | 222 | 655 | 60 | $1,905 |
| Metformin Hcl Generic | 218 | 607 | 70 | $1,365 |
| Metformin Hcl Er Metformin Hcl | 217 | 586 | 56 | $1,662 |
Brand drugs: 1,984 claims; generic drugs: 12,832 claims; opioid claims: 189.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul A Rushing $1,802 ($1,802 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $215.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $215 |
| Abbvie Inc. ABBV | 18 | $214 |
| Amgen Inc. AMGN | 7 | $205 |
| Novo Nordisk Inc NVO | 12 | $199 |
| Lilly USA, LLC LLY | 9 | $164 |
| Dexcom, Inc. DXCM | 5 | $114 |
| Inspire Medical Systems, Inc. INSP | 1 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $93.35 |
| GlaxoSmithKline, LLC. GSK | 5 | $85.89 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $68.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.